Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family. (Q54065729)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

Marja Jäättelä

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

author name string

S S Larsen

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

A E Lykkesfeldt

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

58

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

41-56

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

https://scigraph.springernature.com/pub.10.1023/a:1006232830161

0 references

The type I growth factor receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Epidermal Growth Factor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Expression of the ERBB3 gene product in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Acquired tamoxifen resistance in human breast cancer--potential mechanisms and clinical implications

2 references

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

The significance of heregulin in breast cancer tumor progression and drug resistance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

William L. McGuire Memorial Symposium. Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Epidermal growth factor receptors on human breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Identification of heregulin, a specific activator of p185erbB2

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

21 January 2018

Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of tamoxifen resistance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal and mutant human β-globin pre-mRNAs are faithfully and efficiently spliced in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced anti-proliferative activity of the combination of tamoxifen plus HER-2-neu antibody

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006232830161

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1006232830161

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/10634517

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54065729&oldid=1486668538"